The shares of Arch Capital Group Ltd. (NASDAQ:ACGL) started off the last trading session with the price of $88.74 while closing the day with the price of $88.07. The shares of Arch Capital Group Ltd. (NASDAQ:ACGL) Fell -0.73% with the Loss of -0.67 points.
The shares of Arch Capital Group Ltd. (NASDAQ:ACGL) traded with the day volume of 2.91 Million shares whereas its average trading volume is 538.72 Million.
While analyzing the past performance of the stock we can see that the shares of Arch Capital Group Ltd. (NASDAQ:ACGL) Gain 2.24% in the last week while rising 0.1% in the last month. Past quarter performance shows the red light with -5.16%. The semi-annual and annual performance shows -3.78% and -6.51% respectively.
Some critical values of the shares of Arch Capital Group Ltd. (NASDAQ:ACGL) to be discussed here are: the beta which shows the value at 0.6 while Average True Range of Arch Capital Group Ltd. (NASDAQ:ACGL) demonstrate the value at 2.05. The weekly and monthly volatility of the shares of Arch Capital Group Ltd. (NASDAQ:ACGL) are indicated at 2.36% and 2.53%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 48.86.
While studying the financial position of the shares of Arch Capital Group Ltd. (NASDAQ:ACGL), we can see that the Market capitalization of the company is at 11.61 Billion. The shares outstanding for the company is 131.84 Million and the shares float stands at 125.52 Million. The income of the company stand at 588 Million while the sales stand at 5.49 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 4.21, Price to Earnings or P/E is at 20.91, Price to Sales P/S show the value of 2.11, the Return on Asset ROA stood at 0.018 and the Return on Equity ROE depicted at 0.076 while Return on Investment ROI is at 0.071.
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) started its previous trading session at $6.25 and closed at $4.24 showing a Fell of -42.39 Percent.
The Company traded with an average Volume of 208.81 Million whereas, its Day Volume stood at 2.9 Million.
Looking at the performance of the stock, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Loss -39.43% in the last week in its shares price and -28.62% in the last month. Quarterly performance shows a green of 85.96 Percent while Semi-Annual and Annual performances shows a 96.3 and 0.95 percent respectively.
Beta for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) stands at 1.37 while the ATR (average true range) is at 0.69. The Stock’s Weekly and Monthly Volatility is 17.73% and 10.37% respectively showing a RSI value of 31.25.
While studying the financial position of the shares of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), we can see that the Market capitalization of the company is at 252.11 Million. The shares outstanding for the company is 59.46 Million and the shares float stands at 34.09 Million.
The Company generated an income of -37400000 and the sales of 1.3 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.75 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 193.93 respectively.
The Return on Assets stands at -1.215, ROE shows a value of 6.503 and ROI for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) is -2.196 as of Trailing Twelve Months period.
